Abstract

Background & aims: We created and validated a clinical decision support tool (CDST) to predict outcomes of vedolizumab therapy for ulcerative colitis (UC).

Tags

Antibodies, Monoclonal, Biologic, Personalized Medicine, Prognostic Factor, Response to Treatment, Drug Therapy, Ulcerative Colitis, therapeutic use, Gastrointestinal Agents, Treatment Outcome

Read More